Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Kathryn E. Stephenson, Chen Sabrina Tan, Stephen R. Walsh, Andrew J. Hale, Jessica L. Ansel, Diane G. Kanjilal, Kate Jaegle, Lauren Peter, Erica N. Borducchi, Joseph P. Nkolola,

The Lancet Infectious Diseases · 2020 · 58 citations · 24 references

DOIFull text

Open access

Concepts

References

24